ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01379144
Recruitment Status : Completed
First Posted : June 23, 2011
Last Update Posted : June 23, 2011
Sponsor:
Information provided by:
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2003
  Actual Study Completion Date : April 2003